Skip to main content Accessibility help
×
Home
Hostname: page-component-747cfc64b6-zm8ws Total loading time: 0.212 Render date: 2021-06-14T07:16:56.922Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

Red blood cells membrane vehicle co-delivering DOX and IR780 for effective prostate cancer therapy

Published online by Cambridge University Press:  20 October 2020

Datian Zhang
Affiliation:
Department of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China
Chengfu Zhou
Affiliation:
The First People's Hospital of Tai'an (affiliated to Shandong First Medical University), Tai'an, Shandong 271016, P.R. China
Feng Liu
Affiliation:
Department of Urology, Sixth People's Hospital South Campus Affiliated to Shanghai Jiaotong University, Shanghai 201499, P.R. China
Tao Ding
Affiliation:
Department of Urology, Sixth People's Hospital South Campus Affiliated to Shanghai Jiaotong University, Shanghai 201499, P.R. China
Zhong Wang
Affiliation:
Department of Urology, Sixth People's Hospital South Campus Affiliated to Shanghai Jiaotong University, Shanghai 201499, P.R. China
Corresponding
E-mail address:
Get access

Abstract

The cellular accumulation of drug delivery systems (DDSs) is a critical parameter to determine the final outcome of cancer chemotherapy. Herein, we designed a red blood cells membrane-based vehicle (RV) and employed it to load both doxorubicin (Dox) and IR 780 (RV/I-D). The photothermal-assisted chemotherapy efficacy of RV/I-D on the treatment of cancer was tested on a prostate cancer model. Excitingly, the results showed that RV/I-D was stable and safe nanoparticles with size at about 100 nm. Moreover, upon the increase of system temperature using photothermal effects of IR780, the drug release of the DDS was accelerated. Above all, the DDS also increased the accumulation of drugs into the Dox-resistant prostate cancer cells (PC-3/Dox) both in vitro and in vivo and showed enhanced anticancer performance.

Type
Article
Copyright
Copyright © The Author(s), 2020, published on behalf of Materials Research Society by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below.

References

Daglioglu, C.: Enhancing tumor cell response to multidrug resistance with pH-sensitive quercetin and doxorubicin conjugated multifunctional nanoparticles. Colloids Surf. B 156, 175 (2017).CrossRefGoogle ScholarPubMed
Gong, C., Hu, C., Gu, F., Xia, Q., and Gao, Y.: Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. J. Control. Release 266, 272 (2017).CrossRefGoogle ScholarPubMed
Chen, S-Q., Wang, C., Tao, S., Wang, Y-X., Hu, F-Q., and Yuan, H.: Rational design of redox-responsive and P-gp-inhibitory lipid nanoparticles with high entrapment of paclitaxel for tumor therapy. Adv. Healthcare Mater. 7, 1800485 (2018).CrossRefGoogle ScholarPubMed
Feng, G., Mao, D., Liu, J., Goh, C.C., Ng, L.G., Kong, D., Tang, B.Z., and Liu, B.: Polymeric nanorods with aggregation-induced emission characteristics for enhanced cancer targeting and imaging. Nanoscale 10, 5869 (2018).CrossRefGoogle ScholarPubMed
Graham, K. and Unger, E.: Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. Int. J. Nanomed. 13, 6049 (2018).CrossRefGoogle ScholarPubMed
Hu, D., Chen, L., Qu, Y., Peng, J., Chu, B., Shi, K., Hao, Y., Zhong, L., Wang, M., and Qian, Z.: Oxygen-generating hybrid polymeric nanoparticles with encapsulated doxorubicin and chlorin e6 for trimodal imaging-guided combined chemo-photodynamic therapy. Theranostics 8, 1558 (2018).CrossRefGoogle ScholarPubMed
Zhang, J., Miao, Y., Ni, W., Xiao, H., and Zhang, J.: Cancer cell membrane coated silica nanoparticles loaded with ICG for tumour specific photothermal therapy of osteosarcoma. Artif. Cells Nanomed. Biotechnol. 47, 2298 (2019).CrossRefGoogle ScholarPubMed
Yang, J., Teng, Y., Fu, Y., and Zhang, C.: Chlorins e6 loaded silica nanoparticles coated with gastric cancer cell membrane for tumor specific photodynamic therapy of gastric cancer. Int. J. Nanomed. 14, 5061 (2019).CrossRefGoogle ScholarPubMed
Zhao, X., Tang, D., Wu, Y., Chen, S., and Wang, C.: An artificial cell system for biocompatible gene delivery in cancer therapy. Nanoscale 12, 10189 (2020).CrossRefGoogle ScholarPubMed
Chen, S., Ren, Y., and Duan, P.: Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling. Biomed. Pharmacother. 129, 110371 (2020).CrossRefGoogle ScholarPubMed
Li, C., Wang, X., Li, R., Yang, X., Zhong, Z., Dai, Y., Fan, Q., Lin, Y., Zhang, R., and Liang, T.: Resveratrol-loaded PLGA nanoparticles functionalized with red blood cell membranes as a biomimetic delivery system for prolonged circulation time. J. Drug Delivery Sci. Technol. 54, 101369 (2019).CrossRefGoogle Scholar
Zhou, Z., Zhang, B., Wang, H., Yuan, A., Hu, Y., and Wu, J.: Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles. Theranostics 8, 4898 (2018).CrossRefGoogle ScholarPubMed
Nguyen, T.D.T., Marasini, R., Rayamajhi, S., Aparicio, C., Biller, D., and Aryal, S.: Erythrocyte membrane concealed paramagnetic polymeric nanoparticle for contrast-enhanced magnetic resonance imaging. Nanoscale 12, 4137 (2020).CrossRefGoogle ScholarPubMed
Wang, Z., Liu, W., Shi, J., Chen, N., and Fan, C.: Nanoscale delivery systems for cancer immunotherapy. Mater. Horiz. 5, 344 (2018).CrossRefGoogle Scholar
Li, C., Yang, X-Q., An, J., Cheng, K., Hou, X-L., Zhang, X-S., Hu, Y-G., Liu, B., and Zhao, Y-D.: Red blood cell membrane-enveloped O2 self-supplementing biomimetic nanoparticles for tumor imaging-guided enhanced sonodynamic therapy. Theranostics 10, 867 (2020).CrossRefGoogle ScholarPubMed
Chen, H-H., Lu, I.L., Liu, T-I., Tsai, Y-C., Chiang, W-H., Lin, S-C., and Chiu, H-C.: Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer. Colloids Surf. B 177, 294 (2019).CrossRefGoogle ScholarPubMed
Kostevšek, N., Abramovič, I., Hudoklin, S., Kreft, M.E., Serša, I., Sepe, A., Vidmar, J., Šturm, S., Spreitzer, M., and Ščančar, J.: Hybrid FePt/SiO2/Au nanoparticles as a theranostic tool: In vitro photo-thermal treatment and MRI imaging. Nanoscale 10, 1308 (2018).CrossRefGoogle ScholarPubMed
Han, X., Huang, J., Lin, H., Wang, Z., Li, P., and Chen, Y.: 2D ultrathin MXene-based drug-delivery nanoplatform for synergistic photothermal ablation and chemotherapy of cancer. Adv. Healthcare Mater. 7, 1701394 (2018).CrossRefGoogle ScholarPubMed
Fu, Z., Williams, G.R., Niu, S., Wu, J., Gao, F., Zhang, X., Yang, Y., Li, Y., and Zhu, L-M.: Functionalized boron nanosheets as an intelligent nanoplatform for synergistic low-temperature photothermal therapy and chemotherapy. Nanoscale 12, 14739 (2020).CrossRefGoogle ScholarPubMed
Uthaman, S., Mathew, A.P., Park, H.J., Lee, B-I., Kim, H-S., Huh, K.M., and Park, I-K.: IR 780-loaded hyaluronic acid micelles for enhanced tumor-targeted photothermal therapy. Carbohydr. Polym. 181, 1 (2018).CrossRefGoogle ScholarPubMed
Wang, C., Wang, Z., Zhao, X., Yu, F., Quan, Y., Cheng, Y., and Yuan, H.: DOX loaded aggregation-induced emission active polymeric nanoparticles as a fluorescence resonance energy transfer traceable drug delivery system for self-indicating cancer therapy. Acta Biomater. 85, 218 (2019).CrossRefGoogle ScholarPubMed
Wang, C., Yu, F., Liu, X., Chen, S., Wu, R., Zhao, R., Hu, F., and Yuan, H.: Cancer-specific therapy by artificial modulation of intracellular calcium concentration. Adv. Healthcare Mater. 8, 1900501 (2019).CrossRefGoogle ScholarPubMed
Wang, D., Lee, M.M.S., Xu, W., Kwok, R.T.K., Lam, J.W.Y., and Tang, B.Z.: Theranostics based on AIEgens. Theranostics 8, 4925 (2018).CrossRefGoogle ScholarPubMed
Wang, C., Chen, S., Wang, Y., Liu, X., Hu, F., Sun, J., and Yuan, H.: Lipase-triggered water-responsive “pandora's box” for cancer therapy: Toward induced neighboring effect and enhanced drug penetration. Adv. Mater. 30, 1706407 (2018).CrossRefGoogle ScholarPubMed
Wang, Y., Zhu, P., Li, G., Zhu, S., Liu, K., Liu, Y., He, J., and Lei, J.: Amphiphilic carboxylated cellulose-g-poly (l-lactide) copolymer nanoparticles for oleanolic acid delivery. Carbohydr. Polym. 214, 100 (2019).CrossRefGoogle ScholarPubMed
Yang, X., Yu, T., Zeng, Y., Lian, K., Zhou, X., Li, S., Qiu, G., Jin, X., Yuan, H., and Hu, F.: Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy. Carbohydr. Polym. 240, 116270 (2020).Google ScholarPubMed
Meng, T., Qiu, G., Hong, Y., Yuan, M., Lu, B., Wu, J., Yuan, H., and Hu, F.: Effect of chitosan based glycolipid-like nanocarrier in prevention of developing acquired drug resistance in tri-cycle treatment of breast cancer. Int. J. Pharm. 555, 303 (2019).CrossRefGoogle ScholarPubMed
Tan, L.W., Ma, B.Y., QianZhao, L., Chen, L.J., Peng, J.R., and Qian, Z.Y.: Toxicity evaluation and anti-tumor study of docetaxel loaded mPEG-polyester micelles for breast cancer therapy. J. Biomed. Nanotechnol. 13, 393 (2017).CrossRefGoogle ScholarPubMed
Song, J., Zhang, N., Zhang, L., Yi, H., Liu, Y., Li, Y., Li, X., Wu, M., Hao, L., and Yang, Z.: IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer. Int. J. Nanomed. 14, 2757 (2019).CrossRefGoogle ScholarPubMed
Wu, X., Liu, J., Yang, L., and Wang, F.: Photothermally controlled drug release system with high dose loading for synergistic chemo-photothermal therapy of multidrug resistance cancer. Colloids Surf. B 175, 239 (2019).CrossRefGoogle ScholarPubMed
Yang, G., Wan, X., Gu, Z., Zeng, X., and Tang, J.: Near infrared photothermal-responsive poly (vinyl alcohol)/black phosphorus composite hydrogels with excellent on-demand drug release capacity. J. Mater. Chem. B 6, 1622 (2018).Google ScholarPubMed
Wang, C., Chen, S., Bao, L., Liu, X., Hu, F., and Yuan, H.: Size-controlled preparation and behavior study of phospholipid–calcium carbonate hybrid nanoparticles. Int. J. Nanomed. 15, 4049 (2020).CrossRefGoogle ScholarPubMed
Zhou, B., Song, J., Wang, M., Wang, X., Wang, J., Howard, E.W., Zhou, F., Qu, J., and Chen, W.R.: BSA-bioinspired gold nanorods loaded with immunoadjuvant for the treatment of melanoma by combined photothermal therapy and immunotherapy. Nanoscale 10, 21640 (2018).CrossRefGoogle ScholarPubMed
Zhou, B.G., Wei, C.S., Zhang, S., Zhang, Z., and Gao, H.M.: Matrine reversed multidrug resistance of breast cancer MCF-7/ADR cells through PI3K/AKT signaling pathway. J. Cell. Biochem. 119, 3885 (2018).CrossRefGoogle ScholarPubMed
Zhang, X., Li, Y., Wei, M., Liu, C., and Yang, J.: Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer. Drug Deliv. 26, 129 (2019).CrossRefGoogle ScholarPubMed
Igarashi, K., Li, S., Han, Q., Tan, Y., Kawaguchi, K., Murakami, T., Kiyuna, T., Miyake, K., Li, Y., and Nelson, S.D.: Growth of doxorubicin-resistant undifferentiated spindle-cell sarcoma PDOX is arrested by metabolic targeting with recombinant methioninase. J. Cell. Biochem. 119, 3537 (2018).CrossRefGoogle ScholarPubMed
Negi, L.M., Talegaonkar, S., Jaggi, M., and Verma, A.K.: Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: An in-vitro, in-vivo and mechanistic investigation. J. Drug Target. 27, 183 (2019).CrossRefGoogle ScholarPubMed
Wang, C., Han, M., Liu, X., Chen, S., Hu, F., Sun, J., and Yuan, H.: Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy. Int. J. Nanomed. 14, 1503 (2019).CrossRefGoogle ScholarPubMed
Suski, J.M., Magdalena, L., Aleksandra, W., Jerzy, D., Carlotta, G., Paolo, P., and Wieckowski, M.R.: Isolation of plasma membrane-associated membranes from rat liver. Nat. Protoc. 9, 312 (2014).CrossRefGoogle ScholarPubMed
Zhao, X., Tang, D., Yang, T., and Wang, C.: Facile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumor-penetration delivery system. Colloids Surf. B 170, 355 (2018).CrossRefGoogle ScholarPubMed
Wang, S., Liu, X., Chen, S., Liu, Z., Zhang, X., Liang, X.J., and Li, L.: Regulation of Ca2+ signaling for drug-resistant breast cancer therapy with mesoporous silica nanocapsules encapsulated doxorubicin/siRNA cocktail. ACS Nano 13, 274 (2018).CrossRefGoogle ScholarPubMed

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Red blood cells membrane vehicle co-delivering DOX and IR780 for effective prostate cancer therapy
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Red blood cells membrane vehicle co-delivering DOX and IR780 for effective prostate cancer therapy
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Red blood cells membrane vehicle co-delivering DOX and IR780 for effective prostate cancer therapy
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *